📰 2 sources covering this story

Fresh data backs Amplia push against pancreatic, ovarian cancer

First covered 48 mins ago · latest take 48 mins ago. Compare how each outlet is covering it — and rate the sources you trust.

Fresh data backs Amplia push against pancreatic, ovarian cancer
The Age
The Age🏁 first to report48 mins ago
Fresh data backs Amplia push against pancreatic, ovarian cancer
Amplia Therapeutics has pointed to new preclinical data showing its pancreatic cancer drug candidate narmafotinib can hit several drivers of the intractable disease.
Fresh data backs Amplia push against pancreatic, ovarian cancer
Amplia Therapeutics has pointed to new preclinical data showing its pancreatic cancer drug candidate narmafotinib can hit several drivers of the intractable disease.
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →